Durability and cross-reactivity of SARS-CoV-2 mRNA vaccine in adolescent children
Madeleine D Burns, Brittany P Boribong, Yannic C Bartsch, Maggie Loiselle, Jameson P Davis, Rosiane Lima, Andrea G Edlow, Alessio Fasano, Galit Alter, Lael M Yonker
doi: https://doi.org/10.1101/2022.01.05.22268617
Madeleine D Burns
1Massachusetts General Hospital Department of Pediatrics, Mucosal Immunology and Biology Research Center, Boston, MA, USA
MSBrittany P Boribong
1Massachusetts General Hospital Department of Pediatrics, Mucosal Immunology and Biology Research Center, Boston, MA, USA
PhDYannic C Bartsch
2Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA
PhDMaggie Loiselle
1Massachusetts General Hospital Department of Pediatrics, Mucosal Immunology and Biology Research Center, Boston, MA, USA
Jameson P Davis
1Massachusetts General Hospital Department of Pediatrics, Mucosal Immunology and Biology Research Center, Boston, MA, USA
Rosiane Lima
1Massachusetts General Hospital Department of Pediatrics, Mucosal Immunology and Biology Research Center, Boston, MA, USA
Andrea G Edlow
3Massachusetts General Hospital Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Vincent Center for Reproductive Biology, Boston, MA, USA
MDAlessio Fasano
1Massachusetts General Hospital Department of Pediatrics, Mucosal Immunology and Biology Research Center, Boston, MA, USA
MDGalit Alter
2Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA
PhDLael M Yonker
1Massachusetts General Hospital Department of Pediatrics, Mucosal Immunology and Biology Research Center, Boston, MA, USA
MDData Availability
All data produced in the present study are available upon reasonable request to the authors
Posted February 16, 2022.
Durability and cross-reactivity of SARS-CoV-2 mRNA vaccine in adolescent children
Madeleine D Burns, Brittany P Boribong, Yannic C Bartsch, Maggie Loiselle, Jameson P Davis, Rosiane Lima, Andrea G Edlow, Alessio Fasano, Galit Alter, Lael M Yonker
medRxiv 2022.01.05.22268617; doi: https://doi.org/10.1101/2022.01.05.22268617
Durability and cross-reactivity of SARS-CoV-2 mRNA vaccine in adolescent children
Madeleine D Burns, Brittany P Boribong, Yannic C Bartsch, Maggie Loiselle, Jameson P Davis, Rosiane Lima, Andrea G Edlow, Alessio Fasano, Galit Alter, Lael M Yonker
medRxiv 2022.01.05.22268617; doi: https://doi.org/10.1101/2022.01.05.22268617
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (200)
- Cardiovascular Medicine (2918)
- Dermatology (249)
- Emergency Medicine (438)
- Epidemiology (12711)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4567)
- Geriatric Medicine (415)
- Health Economics (726)
- Health Informatics (2913)
- Health Policy (1068)
- Hematology (386)
- HIV/AIDS (922)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (467)
- Neurology (4335)
- Nursing (234)
- Nutrition (636)
- Oncology (2261)
- Ophthalmology (643)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (278)
- Palliative Medicine (83)
- Pathology (499)
- Pediatrics (1196)
- Primary Care Research (494)
- Public and Global Health (6916)
- Radiology and Imaging (1524)
- Respiratory Medicine (915)
- Rheumatology (436)
- Sports Medicine (383)
- Surgery (486)
- Toxicology (60)
- Transplantation (210)
- Urology (178)